Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Trial of Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients at Risk for Progression

NCT04691765 is registered in ClinicalTrials.gov with Dr. David Spaner as lead sponsor.

NCT NCT04691765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04691765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Trial of Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients at Risk for Progression
Lead sponsor
Dr. David Spaner
Phase
Phase 1
Overall status
Unknown status
Start date
May 1, 2021
Completion date
December 31, 2022
Enrollment
12 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia